MedTrace Logo

Natural History Study of CEP290-Related Retinal Degeneration

NCT03396042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2022-05-19

No results posted yet for this study

Summary

A prospective natural history study with systematic assessments and uniform follow-up to provide a high-quality dataset for assisting in the design of future clinical treatment trials involving patients with CEP290-related retinal degeneration caused by the common intron 26 mutation.

Conditions

  • Blindness
  • Leber Congenital Amaurosis 10
  • Vision Disorders
  • Eye Diseases
  • Eye Diseases, Hereditary
  • Eye Disorders Congenital
  • Retinal Disease
  • Retinal Degeneration

Sponsors & Collaborators

  • Editas Medicine, Inc.

    lead INDUSTRY

Eligibility

Min Age
3 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-17
Primary Completion
2022-05-06
Completion
2022-05-06

Countries

  • United States
  • France
  • Germany
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03396042 on ClinicalTrials.gov